UA-15821650-81
1

Treatment done by Dr. Samer

French dermatologist Dr Thierno BOCOUM is a happy professional because he gets to help many patients with the skin pigmentation problems they encounter while considering a great deal of patient factors.

Both of Dr. BOCOUM’s practices are located in the South of France, a region known for its great food, quality living and year-round sunshine. But sometimes the bountiful sunshine that the region is bathed in can become a problem for those individuals who experience skin pigmentation problems. And this is when he steps in.

The French dermatologist is used to dealing with pigmentation disorders, and he speaks casually about the different approaches in the treatments he opts for, as well as his enthusiasm for the Nunii products he uses. Over the years of medical practice, he says he holds Nunii products in high esteem and it enables him to develop contracts of confidence with patients when they come to his office. Having used many other treatments than Nunii, he has sometimes been very disappointed, and shares his views on his job and the subtleties of his medical approaches.

_ Doctor BOCOUM, could you please briefly introduce yourself?

_ I am a former intern from the Greater Paris hospital network. I have worked for and with the pharmaceuticals industry, and have decided to settle in the South of France: I have had my private practice since 2016, and now run 2 different offices, one located in Valbonne, between Nice and Cannes, and another one in a charming provençal town of Roquebrune-sur-Argens, in the Var.

Regarding the types of skin pathologies I deal with, a great deal of the patients who visit my offices suffer from skin pigmentation disorders – about 20 to 25% of my patients actually – which isn’t negligible. The most common diseases I see are melasma and solar lentigo, otherwise known as sun spots. Obviously, the wide range of individuals living in or visiting our sunny region are subject to strong UV exposure; this is no coincidence.

_ In such situations, which options do you have to treat patients then?

_ Well, actually there are 3 different approaches to use, and this closely depends on the specificity of the patient:

The first choice consists in treating the patients with creams available in the pharmacy without prescription, but they only partially and temporarily solve the problem: the improvement is quite superficial and short-lived compared to other solutions; this is the main reason why I do not personally prescribe such treatments.

The other option is the use of peelings, such as the Nunii Laboratoire protocol. I have personally conducted a before/after study on its effects, and I must say that the treatment leads to a significant reduction of pigmentation spots on patient skin.

As a last alternative I will use the laser. This is however an expensive type of treatment, and is appropriate only to treat highly local areas of pigmented skin, such as the facial area or hands. It isn’t suitable to treat melasma, which is usually widespread on the body surface. What’s more, laser therapy isn’t suitable or recommended to be used on darker skin types. And let’s not forget that although this isn’t the main factor, the patient’s budget also helps determine which option I will choose from in designing a treatment protocol for hyperpigmentation disorders, and laser technology isn’t really affordable for all patients.

_ You mentioned that you use Nunii products; which aspects of these products do you specifically appreciate in your practice?

_ Well, I am very sensitive to innovation, and new products and treatments coming up and helping the patient more and more as the years go by, are quite interesting and triggered my curiosity. And Nunii does exactly that through their range of their innovative products: the company has developed products that have different active ingredients than those commonly found in most depigmentation products, such as hydroquinone.

Thanks to the use of Nunii products and treatment protocol to which targets hyperpigmentation, my patients skin peels less than with other formulations, which is a gentler way of dealing with such problems, and results show quite quickly also, which is a plus.  The only slight inconvenience however is that Nunii products is that the treatment must be most often conducted by a physician in his/her office, which is a bit time-consuming for patients who do not always have a great deal of available time among busy schedules.

Nunii products also have another benefit: since darker skin types are very much affected by hyperpigmentation disorders, and that the laser option is not a viable option. Nunii comes in really conveniently for these patients who have darker skin types. Thanks to Nunii products, the proposed treatment is very safe and there is no risk of seeing a case of post inflammatory hyperpigmentation develop, since the opposite effect is what is sought.

_ In your practice, you mention the time factor quite often: why is it that important in your view?

_ Well, it’s in human nature to be very concerned with a disorder when this disorder is serious: most of my patients that are severely affected by their pigmentation disorders will show great rigor in following their treatment right from the first time they consult with me. The other patients display various levels of motivation on the other hand; it seems difficult for them to stick to the at-home part of their treatment or to call for new appointments, and mostly because there is no doctor checking on them (he smiles).

I must however point out that the at-home part of the treatment greatly helps if patients are motivated enough. In general, the determining factor to (re)gain motivation and rigor for a patient is almost invariably when the skin condition gets better, when the spots tend to be less visible and that the pigmentation surface of spots shrinks; only then will they be encouraged to continue and be more rigorous on a daily basis, as well as in the following steps of their treatment.

Throughout the comments and explanations of Dr. BOCOUM in the treatment of pigmentation disorders, it is interesting to notice that not only does a medical approach need to be carefully designed for each patient, but also that the patient’s role is paramount in the level of success of a protocol, and the time frame within which success will be reached.

Since aesthetic medicine is not eligible for reimbursement by health plans, it is crucial that evidence of improvement in treatments show quickly in the process of improving patient skin condition: tangible and lasting result should appear within the first ten days so that patients can be more inclined to follow a given skin treatment protocol. This is obviously when certified medical and validated advice become the essential part of a patient’s motivation to deal with his/her pigmentation disorders.

Photographie : (c) Droits réservés